双源双能量肝脏CT碘定量鉴别肝神经内分泌肿瘤转移与肝细胞癌
回顾性纳入46例非肝硬化肝脏患者,评估第三代双源双能量CT的碘摄取、标准化碘摄取(NIU)等参数鉴别肝神经内分泌肿瘤转移与肝细胞癌。NIU敏感度100%、特异度90%,碘摄取特异度100%,NIU诊断效能最强。
要点
- NIU鉴别肝NET转移与HCC敏感度100%、特异度90%,诊断效能最强。
- 碘摄取特异度100%、敏感度71%,与NIU均优于LPR和动脉期衰减分析。
- 动脉期衰减、碘摄取、NIU、LPR在两组间差异显著;平扫衰减和脂肪分数无显著差异。
核心结论
- 第三代双源双能量CT碘摄取评估改善非肝硬化肝脏中肝NET转移与HCC的鉴别,NIU诊断效能最强。
研究设计与样本
- 回顾性研究纳入46例患者(平均年龄64.9±10.1岁,男28例、女18例),行肝脏双源双能量CT,以组织病理学、MRI、PET/CT或间期影像随访为参考标准。
关键影像表现/征象
- 肝NET转移与HCC在动脉期衰减(P=0.003)、碘摄取(P<0.001)、NIU(P<0.001)和LPR(P=0.003)上差异显著。
- 平扫衰减和脂肪分数在两组间无显著差异(P=0.686和P=0.892)。
诊断标准与关键数值
- NIU敏感度100%、特异度90%;碘摄取敏感度71%、特异度100%。
- LPR敏感度96%、特异度80%;动脉期衰减分析敏感度79%、特异度80%。
- NIU与碘摄取在敏感度或特异度上优于LPR和动脉期衰减分析(P≤0.016)。
临床应用与阅片要点
- 作者认为第三代双源双能量CT碘摄取评估可改善非肝硬化肝脏中肝NET转移与HCC的鉴别。
- NIU在鉴别诊断中表现出最强的诊断性能。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the value of third-generation dual-source dual-energy computed tomography (DECT) iodine quantification to distinguish hepatic neuroendocrine tumor (NET) metastasis from hepatocellular carcinoma (HCC) in non-cirrhotic liver parenchyma.
MATERIAL AND METHODS: Forty-six patients (mean age, 64.9 ± 10.1 years; 28 male and 18 female) with either hepatic NET metastasis or HCC, who had undergone liver DECT, were included in this retrospective study. For each lesion, arterial-phase attenuation values and DECT quantitative parameters, including iodine uptake, fat fraction, normalized iodine uptake (NIU), and lesion-to-liver-parenchyma ratio (LPR) were evaluated. Available cumulative data from histopathology, MRI, PET/CT, or interval imaging follow-up served as the reference standard for all liver lesions. In addition, the diagnostic accuracy of contrast-enhanced and material decomposition analysis for the differentiation of hepatic NET metastasis and HCC was assessed using receiver operating characteristics (ROC) curve analysis.
RESULTS: Hepatic NET metastasis and HCC showed significant differences in arterial attenuation (P = 0.003), iodine uptake (P < 0.001), NIU (P < 0.001), and LPR (P = 0.003). No significant differences were found for unenhanced attenuation and fat fraction values (P = 0.686 and P = 0.892, respectively). NIU showed superior sensitivity (100%; iodine uptake, 71%), while both iodine uptake and NIU revealed superior specificity (100% and 90%, respectively) compared to LPR (sensitivity, 96%; specificity, 80%) and arterial attenuation analysis (sensitivity, 79%; specificity, 80%) (P ≤ 0.016).
CONCLUSION: Third-generation DECT with assessment of iodine uptake improves the differentiation of hepatic NET metastasis and HCC in non-cirrhotic liver, with NIU showing the strongest diagnostic performance.
引用
- Kaltenbach B, Wichmann JL, Pfeifer S, et al. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT. Eur J Radiol. 2018. PMID: 30017280. doi:10.1016/j.ejrad.2018.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。